Skip to content

Harm-reduction information only — not medical advice. In crisis or experiencing adverse effects, contact a healthcare professional or your local emergency services immediately.

AnabolicDex logo AnabolicDex
Search (no-JS fallback)
Peptides Muscle BuildingRecovery & Healing Preclinical (animal) data

PEG-MGF (Pegylated MGF)

PEG-MGF

19.2 hours
Half-life
200–800 mcg
Typical dose
4–6 weeks (reported)
Cycle length

Pegylated mechano growth factor with extended half-life versus native MGF; used for recovery research.

Key takeaways

  • PEGylated MGF: same satellite-cell peptide, half-life stretched to ~19 hours (estimated).
  • Longer action allows weekly-ish dosing but loses the local, pulsatile character of native MGF.
  • Zero human studies; all dosing numbers are community extrapolations from animal work.
  • WADA-prohibited as a growth factor under S2.3.

Overview

What it is

PEG-MGF is mechano growth factor, the IGF-1Ec splice variant muscle releases after overload, with a polyethylene glycol chain attached. PEGylation shields the peptide from rapid enzymatic breakdown. Like native MGF, it targets satellite-cell activation and local repair signaling.

Pharmacokinetics

PEGylation stretches the half-life from roughly 30 minutes to an estimated 19 hours, with subcutaneous bioavailability near 60%. The longer residence supports once- or twice-weekly dosing instead of the post-workout timing native MGF requires.

What the evidence says

No human trials or registered human studies exist for PEG-MGF. Support comes from rodent muscle-injury models and in vitro satellite-cell work, with the PEGylation pharmacology inferred from better-characterized PEGylated drugs. It isn't an approved medication, and WADA prohibits growth factors for tested athletes.

Reported dosing protocols

Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.

Use case Dose Route Frequency Duration
Recovery / muscle repair (community) 200–400 mcg SubQ 1–2× weekly 4–6 weeks

Pharmacokinetic summary

Model tier
Simple (t½ + F, Tmax estimated)
Half-life
19.2 hours
Bioavailability
60%
Typical dose
0.2–0.8 mg

Frequently asked questions

Why pegylate MGF at all?

Native MGF degrades within minutes, which makes practical dosing nearly impossible. Attaching a PEG chain is a standard drug-delivery trick that slows enzymatic breakdown and clearance, stretching the half-life from minutes to roughly a day.

Is PEG-MGF better than regular MGF?

Different, not proven better. PEG-MGF is convenient, but animal biology suggests MGF works as a short local pulse after damage. Whether a day-long systemic exposure preserves that repair signaling is untested, and no human data exists for either form.

Is PEG-MGF banned in sport?

Yes. WADA prohibits growth factors and their mimetics under section S2.3, which covers MGF and pegylated variants. The MGF E-domain peptide is detectable in urine by LC-MS, so tested athletes should treat it as a clear anti-doping violation.

References

Related compounds

Comments

Loading comments…